LONDON and MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress evaluating specific monoclonal antibodies for Cizzle’s CIZ1B cancer biomarker. Cizzle has successfully completed an evaluation programme aimed at assessing the feasibility of using the Simple Western platform from ProteinSimple (a Bio-Techne Brand) for high […]

Veteran biotech executive to head commercial partnerships to accelerate drug discovery SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Julie Gerardi has joined the company as vice president of business development. Gerardi will lead commercial strategy for large scale applications of Parse’s Evercode Whole Transcriptome, Evercode […]

PALO ALTO, Calif. — Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, and Kytopen, a leader in the development and commercialization of non-viral transfection tools for genome engineering, today announced a partnership to bring the power of cloud native, structured data to Kytopen’s Flowfect® platforms. Under this collaboration, the Kytopen transfection systems will […]

DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work BOULDER, Colo. and SEOUL, Korea — SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with DNA Link, an innovator in personalized and precision medicine, to offer the 7,000-plex SomaScan® platform to […]

The collaboration represents MilliporeSigma’s joint steps toward breakthrough innovation to make research and quality control in the lab more efficient and sustainable. The new ChemisTwin™ platform combines ACD/Labs’ industry-leading NMR predictors with Millipore Sigma’s digital reference materials (dRMs). ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced a collaboration […]

SAN CARLOS, Calif. and BOSTON — Factorial Biotechnologies, an emerging single-cell sequencing company with a novel intracellular library preparation technology, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration. Through this partnership, Factorial will leverage Ginkgo Enzyme Services to develop a novel isothermal DNA polymerase for […]

Gilson has partnered with ShinYoung Corporation to give more researchers access to manual liquid handling tools (pipettes and pipette tips) as well as PIPETMAX®, PLATEMASTER®, and pipette service in South Korea. Broadening channel availability with ShinYoung Corporation provides another convenient and fast way for researchers to get lab supplies and calibrate and repair their tools […]

Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic CORALVILLE, Iowa and FARGO, N.D. — Leading CRISPR gene editing companies, Integrated DNA Technologies and Aldevron, inked a new global distribution agreement to expand key CRISPR solutions for cell and gene […]

ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement Demeetra to broaden synthetic biology and bioprocessing technology through combined CRISPR/Cas9 IP and Demeetra’s own dimeric Cas-CLOVER. Dublin, Ireland and Kentucky, USA, September 12: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Demeetra AgBio (‘Demeetra’). This is a non-exclusive licensing agreement […]

As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products DURHAM, N.C. – BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced […]